Paul Whelton
Whelton, Paul K. (Paul Kieran), 1946-
Whelton, Paul K.
Whelton, Paul K., 19..-....
Whelton, Paul K. 1946-
Whelton, Paul Kieran
Whelton, Paul Kieran 1946-
Whelton, Paul K. (Paul Kieran)
VIAF ID: 268278792 (Personal)
Permalink: http://viaf.org/viaf/268278792
Preferred Forms
- 100 0 _ ‡a Paul Whelton
-
-
- 100 1 _ ‡a Whelton, Paul K. ‡d 1946-
- 100 1 _ ‡a Whelton, Paul K. ‡q (Paul Kieran)
- 100 1 0 ‡a Whelton, Paul K. ‡q (Paul Kieran), ‡d 1946-
-
- 100 1 _ ‡a Whelton, Paul K., ‡d 19..-....
-
- 100 1 _ ‡a Whelton, Paul Kieran ‡d 1946-
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
ALLHAT: setting the record straight | |
Association between chronic kidney disease and cancer mortality: A report from the ALLHAT. | |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension | |
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. | |
Epidemiology and prevention of blood pressure-related renal disease | |
Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project | |
The glycemic effects of antihypertensive medications | |
Lifestyle modification for the prevention and treatment of hypertension | |
Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study | |
Potassium in cardiovascular and renal medicine : arrhythmias, myocardial infarction, and hypertension | |
Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes | |
Re: Hawkins RG, Houston MC Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens. 2005 Jun;18(6):744-9 | |
Research Needs to Improve Hypertension Treatment and Control in African Americans | |
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT. | |
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). | |
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT. |